Westmead Medical Research Foundation is governed and supported by a dynamic, highly-skilled and well-connected Board of Directors. Each member of the Board is passionately involved in the success of the Foundation.
Mr Richard Alcock, AO
WMRF Board Chair since February 2018.
Vice Chairman of Bank of America Merrill Lynch since 2017.
Western Sydney Local Health District Board Chair since August 2016.
In 2017, Mr Alcock was awarded the Officer (AO) in the General Division, for distinguished service to the community, particularly through health management roles, and to the law, corporate governance, and higher education organisations.
Prior to his appointment to the SCHN board, Mr Alcock was a director of the Sydney Children’s Hospitals Foundation and acted as deputy chairman and chairman of its Finance and Performance Committee.
Mr Alcock has been Managing Director and Co-Head of Transport, Infrastructure, Power & Utilities at Merrill Lynch Markets (Australia) Pty Limited from 2007.
Mr Alcock was a corporate lawyer for 25 years with Allens Arthur Robinson; he worked in Sydney, Singapore and Jakarta, was made a senior partner, head of Governance, and chairman of the Ethics Committee.
He is also a director of both the UNSW Foundation Limited and Art Exhibitions Australia Limited.
Mr David Borger
Western Sydney Director of the Sydney Business Chamber
Professor Jeremy Chapman, AC
Director — Division of Medicine and Cancer Services, Westmead Hospital
Professor Tony Cunningham, AO
Executive Director, The Westmead Institute for Medical Research
Mr Danny O’Connor
Chief Executive, Western Sydney Local Health District
Mr Mathew Nott
Director Corporate Communications, Western Sydney Local Health District
Mr Ray Horne
Head of Development
Community Relations & Events Manager
Marketing & Development Manager
Senior Trust Fund Administrator
Finance & Administrator